Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes: genes and variants
Explore variant evidence for Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes across 4 analyzed proteins (MTOR, PIK3CA, PIK3R2, AKT3). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 10 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
MTOR: Serine/threonine-protein kinase mTOR
It integrates nutrient, energy, oxygen, and growth-factor signals to control protein synthesis, autophagy, metabolism, and cell growth. Activating germline or mosaic variants can cause developmental brain overgrowth and epilepsy, while persistent pathway activation is common in cancer.
12 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in MTOR have source records linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes. Association strength is not clinical gene validity.
PIK3CA: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Its p110-alpha catalytic activity generates PIP3 and activates AKT-dependent growth, survival, and metabolic signaling downstream of many receptors. Activating variants are frequent cancer drivers and, when present mosaically during development, can cause PIK3CA-related overgrowth spectrum.
4 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in PIK3CA have source records linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes. Association strength is not clinical gene validity.
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta
The p85β regulatory subunit of class IA phosphoinositide 3-kinase, which helps control PI3K–AKT signaling and cell growth. Specific activating variants cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PIK3R2 have source records linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes. Association strength is not clinical gene validity.
AKT3: RAC-gamma serine/threonine-protein kinase
It is especially important for growth and survival signaling in the developing brain. Activating mosaic or germline variants can cause megalencephaly and cortical malformation syndromes, while loss-of-function variants can be associated with microcephaly and neurodevelopmental impairment.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AKT3 have source records linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes. Association strength is not clinical gene validity.
Where Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants cluster
- MTOR TPR 5 (positions 1474–1507): 3 of 12 ClinVar pathogenic / likely pathogenic variants, 18.7× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MTOR C1483R | 1483 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR C1483Y | 1483 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR T1977K | 1977 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR T1977R | 1977 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR S2215F | 2215 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★★) |
| MTOR S2215Y | 2215 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★★) |
| AKT3 E17K | 17 | PH | Pathogenic / likely pathogenic (★★★) |
| PIK3CA G914R | 914 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★★) |
| MTOR L1460P | 1460 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR W1490R | 1490 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR L2427P | 2427 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★★) |
| PIK3R2 G373R | 373 | SH2 1 | Pathogenic / likely pathogenic (★★★) |
| PIK3CA E542K | 542 | PIK helical | Pathogenic / likely pathogenic (★★★) |
| PIK3CA E726K | 726 | Pathogenic / likely pathogenic (★★★) | |
| PIK3CA H1047R | 1047 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★★) |
| MTOR A1669S | 1669 | FAT | Pathogenic / likely pathogenic (★★★) |
| MTOR E1799K | 1799 | FAT | Pathogenic / likely pathogenic (★★) |
| MTOR E2419K | 2419 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
Which prediction tools work for Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 89 out of 100
- CATVariant: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 80 out of 100
- SIFT: 61 out of 100
Same protein, different disease
- Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (13 pathogenic / likely pathogenic).
- Isolated focal cortical dysplasia also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (9 pathogenic / likely pathogenic).
- CEBALID syndrome also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (6 pathogenic / likely pathogenic).
- PIK3CA related overgrowth syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (30 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (23 pathogenic / likely pathogenic).
- Megalencephaly-capillary malformation-polymicrogyria syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (22 pathogenic / likely pathogenic).
- Ovarian neoplasm also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (5 pathogenic / likely pathogenic).
- PIK3CA constitutional syndrome also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (4 pathogenic / likely pathogenic).
- Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome also has ClinVar records linked to PIK3R2 variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (6 pathogenic / likely pathogenic).
- Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome also has ClinVar records linked to AKT3 variants; they fall mostly in different places as the Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes variants (8 pathogenic / likely pathogenic).
Diseases related to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
- Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, also linked to AKT3 and PIK3R2
- Noonan syndrome, also linked to PIK3CA
- Cowden syndrome, also linked to PIK3CA
- Ovarian cancer, also linked to PIK3CA
- PIK3CA related overgrowth syndrome, also linked to PIK3CA
- Hereditary breast cancer, also linked to PIK3CA
- Megalencephaly-capillary malformation-polymicrogyria syndrome, also linked to PIK3CA
- Colorectal cancer, also linked to PIK3CA
- Gastric cancer, also linked to PIK3CA
- Urinary bladder cancer, also linked to PIK3CA
- Non-small cell lung carcinoma, also linked to PIK3CA
- Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, also linked to MTOR
Frequently asked questions
Which genes have records linked to Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes?
This view contains 4 analyzed proteins: MTOR, PIK3CA, PIK3R2, AKT3. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 18 pathogenic or likely pathogenic variants, 10 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 39 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center